That was exactly what I was going to suggest. Why don't we find a happy compromise and go with two?
I'm noting down—very roughly, of course—that we only have about 20 meetings before the fall session is over. Realistically, the math is something we need to look at.
Particularly, I think it's important to recognize that we have not finished some of the work from the last session. We have still not finished our vaccine equity study. We have still not finished some of the studies that were brought forward at that point.
When we look at things brought forward by Ms. Bendayan, Mr. Genuis, Mr. Bergeron and Mr. Zuberi, it's relevant to consider the time. Two meetings would be appropriate.